Show simple item record

dc.contributor.advisorBuitrago Bernal, Ricardo Antonio
dc.contributor.advisorOliveros Rodríguez, Henry
dc.contributor.authorSantacruz Herrera, Carlos Andrés
dc.date.accessioned2012-03-13T21:25:40Z
dc.date.available2012-03-13T21:25:40Z
dc.date.created2011
dc.date.issued2011
dc.identifier.citationAshbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in Adults. Lancet 1967; 290: 319-323.
dc.identifier.citationThomas L Petty, David G Ashbaugh. The Adult Respiratory Distress Syndrome: Clinical Features, Factors Influencing Prognosis and Principles of Management. Chest 1971; 60; 233-239
dc.identifier.citationBernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, et al. The AmericanEuropean Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818-824
dc.identifier.citationPapazian L, et al. Neuromuscular Blockers in Early Acute Respiratory Distress Syndrome. N Engl J Med 2010; 363: 1107-16
dc.identifier.citationChristian Brun-Buisson, Francois Lemaire, et al. Epidemiology and outcome of acute lung injury in European intensive care units: Results from the ALIVE study. Intensive Care Med 2004; 30: 51-61
dc.identifier.citationMario A. Domínguez Perera. Algunas consideraciones bioéticas en el paciente critico. Rev Cub Med Int Emerg 2003;2(84-92)
dc.identifier.citationLaurence L. Brunton, John S. Lazo, Keith L. Parker. Principios generales. Goodman y Gilman. Las bases farmacológicas de la terapéutica 11ª Edición. Sección 1. Pag 12-13;2006
dc.identifier.citationJean-Louis Vincent, Massimo Zambon. Why do patients who have acute lung Injury/Acute Respiratory Distress Syndrome die from Multiple Organ Dysfunction Syndrome? Implications for Management. Clin Chest Med 2006; 27: 725-731
dc.identifier.citationRaoof S, Goulet K, Esan A, Hess DR, Sessler CN. Severe Hypoxemic Respiratory Failure Part 2. Nonventilatory Strategies. Chest 2010; 137(6): 1437-48.
dc.identifier.citationWare LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000; 342: 1334- 1349.
dc.identifier.citationThe National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Higher versus Lower Positive End-Expiratory Pressures in Patients with the Acute Respiratory Distress Syndrome. N Engl J Med 2004; 351: 327-36
dc.identifier.citationMatthias Briel, Maureen Meade, Alain Mercat, et al. Higher vs. Lower positive end-expiratory pressure in patients with Acute Lung Injury and Acute Respiratory Distress Syndrome. Systematic Review and Meta-analysis. JAMA 2010; 303(9): 865-873 (doi:10.1001/jama.2010.218).
dc.identifier.citationJason Phua, Niall D Ferguson, et al. Has Mortality from Acute Respiratory Distress Syndrome Decreased Over Time? A Systematic Review. AJRCCM Articles in Press. Am J Respir Crit Care Med 2010.
dc.identifier.citationShariatpanahi ZV, Taleban FA, Mokhtari M, Shahbazi S. Ginger extract reduces delayed gastric emptying and nosocomial pneumonia in adult respiratory distress syndrome patients hospitalized in an intensive care unit. J Crit Care 2010; 25(4): 647-50. Epub 2010 Feb 10.
dc.identifier.citationLu Q, Zhang M, Girardi C, Bouhemad B, Kesecioglu J, Rouby JJ. Computed tomography assessment of exogenous surfactant-induced lung reaeration in patients with acute lung injury. Crit Care 2010; 14(4): R135. Epub 2010 Jul 15.
dc.identifier.citationMichelle Ng Gong, MD, MS. Genetic Epidemiology of Acute Respiratory Distress Syndrome: Implications for Future Prevention and Treatment. Clin Chest Med 2006; 27(4): 705-x. doi:10.1016/j.ccm.2006.07.001
dc.identifier.citationAnita J Reddy, Steven R Kleeberger. Genetic polymorphisms associated with acute lung injury. Pharmacogenomics 2009; 10(9): 1527-1539. doi:10.2217/pgs.09.89.
dc.identifier.citationAdhikari Neill KJ, Burns Karen EA, Meade Maureen O, Ratnapalan Mohana. Pharmacologic therapies for adults with acute lung injury and acute respiratory distress syndrome. Cochrane Database of Systematic Reviews. In: The Cochrane Library, Issue 10, Art. No. CD004477. DOI: 10.1002/14651858.CD004477.pub4.
dc.identifier.citationJan O Friedrich, et al. Prone ventilation reduces mortality in patients with acute respiratory failure and severe hypoxemia: systematic review and meta-analysis. Intensive Care Med 2010; 36: 585-599
dc.identifier.citationMeduri U, et al. Methylprednisolone Infusion in Early Severe ARDS Results of a Randomized Controlled trial. Chest 2007; 131; 954-963
dc.identifier.citationGadek J, et al. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine 1999; 27.
dc.identifier.citationSinger P, et al. Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit Care Med 2006; 34(4).
dc.identifier.citationPontes-Arruda, et al. The Use of an Inflammation-Modulating Diet in Patients with Acute Lung Injury or Acute Respiratory Distress Syndrome: A Meta-Analysis of Outcome Data. JPEN J Parenter Enteral Nutr 2008; 32: 596.
dc.identifier.citationAbroug, et al. An updated study-level meta-analysis of randomized controlled trials on proning in ARDS and acute lung injury. Critical Care 2011; 15: R6.
dc.identifier.citationFriedrich, et al. Prone ventilation reduces mortality in patients with acute respiratory failure and severe hypoxemia: systematic review and meta-analysis. Intensive Care Med 2010; 36: 585-599.
dc.identifier.citationKaren A Roberston, Kay Dickersin. Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed. International Journal of Epidemiology 2002;31:151-153
dc.identifier.citationHiggins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011
dc.identifier.citationHiggins, et al. Quantifying heterogeneity in a meta-analysis. Statist Med 2002; 21: 1539-1558.
dc.identifier.urihttp://hdl.handle.net/10818/1403
dc.description20 Páginas.
dc.description.abstractTratamientos farmacológicos en SDRA El síndrome de distrés respiratorio agudo es una enfermedad común en la unidad de cuidados intensivos, con alta mortalidad y sin un tratamiento farmacológico recomendado. Se desea una revisión de la literatura y posible meta-análisis de los ECC en pacientes con SDRA que evalúen la eficacia de los tratamientos farmacológicos en pacientes con SDRA en los desenlaces, la disfunción de múltiples órganos, el hospital / UCI duración de la estancia de días libres de ventilación mecánica al compararlos con la terapia estándar Se incluirán los ECA de tratamiento farmacológicos que valoren mortalidad en adultos,> 18 años de edad. Se excluirán niños, mujeres embarazadas, animales y ECA sin definición de SDRA. Los resultados no están disponibles todavíaes_CO
dc.language.isospaes_CO
dc.publisherUniversidad de La Sabana
dc.sourceUniversidad de La Sabana
dc.sourceIntellectum Repositorio Universidad de La Sabana
dc.subjectTerapia respiratoriaes_CO
dc.subjectCuidados intensivos (Medicina)es_CO
dc.subjectUnidades de cuidados intensivos-Atención al enfermoes_CO
dc.subjectInsuficiencia respiratoria-Tratamientoes_CO
dc.subjectSíndrome de dificultad respiratoria-Tratamientoes_CO
dc.titleTratamientos farmacológicos en pacientes con Síndrome de Dificultad Respiratoria Aguda (SDRA): Revisión sistemática y meta-análisises_CO
dc.typebachelorThesis
dc.publisher.programEspecialización en Medicina Crítica y Cuidado Intensivo
dc.publisher.departmentFacultad de Medicina
dc.identifier.local151760
dc.identifier.localTE00159
dc.type.localTesis de especialización
dc.type.hasVersionpublishedVersion
dc.rights.accessRightsopenAccess
dc.creator.degreeEspecialista en Medicina Crítica y Cuidado Intensivo


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record